608 related articles for article (PubMed ID: 26123862)
1. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
[TBL] [Abstract][Full Text] [Related]
2. Uses of proton pump inhibitors and hypomagnesemia.
Gau JT; Yang YX; Chen R; Kao TC
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):553-9. PubMed ID: 22337212
[TBL] [Abstract][Full Text] [Related]
3. The association of proton pump inhibitors and hypomagnesemia in the community setting.
Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
[TBL] [Abstract][Full Text] [Related]
4. Thiazide but not loop diuretics is associated with hypomagnesaemia in the general population.
Kieboom BCT; Zietse R; Ikram MA; Hoorn EJ; Stricker BH
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1166-1173. PubMed ID: 30095199
[TBL] [Abstract][Full Text] [Related]
5. Proton-pump inhibitor use is associated with low serum magnesium concentrations.
Danziger J; William JH; Scott DJ; Lee J; Lehman LW; Mark RG; Howell MD; Celi LA; Mukamal KJ
Kidney Int; 2013 Apr; 83(4):692-9. PubMed ID: 23325090
[TBL] [Abstract][Full Text] [Related]
6. Hypomagnesemia Among Outpatient Long-Term Proton Pump Inhibitor Users.
Biyik M; Solak Y; Ucar R; Cifci S; Tekis D; Polat İ; Göktepe MH; Sakiz D; Ataseven H; Demir A
Am J Ther; 2017; 24(1):e52-e55. PubMed ID: 25353358
[TBL] [Abstract][Full Text] [Related]
7. Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study.
Nakashima A; Ohkido I; Yokoyama K; Mafune A; Urashima M; Yokoo T
PLoS One; 2015; 10(11):e0143656. PubMed ID: 26618538
[TBL] [Abstract][Full Text] [Related]
8. Hypomagnesemia as a predictor of mortality in hemodialysis patients and the role of proton pump inhibitors: A cross-sectional, 1-year, retrospective cohort study.
Ago R; Shindo T; Banshodani M; Shintaku S; Moriishi M; Masaki T; Kawanishi H
Hemodial Int; 2016 Oct; 20(4):580-588. PubMed ID: 27329549
[TBL] [Abstract][Full Text] [Related]
9. Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study.
Koulouridis I; Alfayez M; Tighiouart H; Madias NE; Kent DM; Paulus JK; Jaber BL
Am J Kidney Dis; 2013 Oct; 62(4):730-7. PubMed ID: 23664547
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
Luk CP; Parsons R; Lee YP; Hughes JD
Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
[TBL] [Abstract][Full Text] [Related]
12. The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study.
Misra PS; Alam A; Lipman ML; Nessim SJ
BMC Nephrol; 2015 Aug; 16():136. PubMed ID: 26268579
[TBL] [Abstract][Full Text] [Related]
13. Clinical predictors associated with proton pump inhibitor-induced hypomagnesemia.
Kim S; Lee H; Park CH; Shim CN; Lee HJ; Park JC; Shin SK; Lee SK; Lee YC; Kim HY; Kang DR
Am J Ther; 2015; 22(1):14-21. PubMed ID: 23846522
[TBL] [Abstract][Full Text] [Related]
14. Hypomagnesemia in hemodialysis patients: role of proton pump inhibitors.
Alhosaini M; Walter JS; Singh S; Dieter RS; Hsieh A; Leehey DJ
Am J Nephrol; 2014; 39(3):204-9. PubMed ID: 24577494
[TBL] [Abstract][Full Text] [Related]
15. Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study.
Kim B; Jung JH; Han K; Kang S; Lee E; Chung H; Kim SG; Cho SJ
J Korean Med Sci; 2023 Apr; 38(13):e99. PubMed ID: 37012686
[TBL] [Abstract][Full Text] [Related]
16. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.
Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G
Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924
[TBL] [Abstract][Full Text] [Related]
17. Impact of proton pump inhibitor use on magnesium homoeostasis: a cross-sectional study in a tertiary emergency department.
Lindner G; Funk GC; Leichtle AB; Fiedler GM; Schwarz C; Eleftheriadis T; Pasch A; Mohaupt MG; Exadaktylos AK; Arampatzis S
Int J Clin Pract; 2014 Nov; 68(11):1352-7. PubMed ID: 24898571
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients.
Chen KP; Lee J; Mark RG; Feng M; Celi LA; Malley BE; Danziger J
J Clin Pharmacol; 2015 Jul; 55(7):774-9. PubMed ID: 25655574
[TBL] [Abstract][Full Text] [Related]
19. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG
Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study.
Bahtiri E; Islami H; Hoxha R; Gashi A; Thaçi K; Karakulak Ç; Thaçi S; Qorraj Bytyqi H
Turk J Gastroenterol; 2017 Mar; 28(2):104-109. PubMed ID: 28082254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
